Peptides for Inflammation: What the Evidence Says and What to Ask a Clinician

Some peptides appear to influence inflammation-related pathways, tissue repair, immune signaling, or oxidative stress, but evidence varies widely by peptide. FDA-approved peptide medicines have stronger safety data than experimental peptides such as BPC-157 or TB-500. Anyone considering peptides for inflammation should start with a licensed clinician evaluation rather than buying unregulated products online.

What are peptides, and why are people using them for inflammation?

Peptides are short chains of amino acids, the same building blocks that make up proteins. Some peptides act like messages: they can tell cells to release hormones, repair tissue, make collagen, or change immune signaling.

Inflammation is not always bad. Acute inflammation is the short-term immune response that helps the body respond to infection or injury. Chronic inflammation lasts longer and can involve cytokines such as TNF-alpha, IL-6, and IL-1 beta, oxidative stress, and pathways such as NF-kB 1.

People often search for peptide therapy for joint pain inflammation, sports injury recovery, skin inflammation, metabolic inflammation, arthritis, or autoimmune conditions. The hard part is that online claims often move faster than human data. A mechanism in cells or animals does not prove a clinical benefit in people.

Which peptides are commonly discussed for inflammation?

Inflammation-focused peptide discussions usually group together very different compounds. Some are prescription drugs with human outcome trials. Others are topical or injectable compounded medications. Others are experimental research peptides with limited human safety data.

GHK-Cu

GHK-Cu, also called glycyl-L-histidyl-L-lysine copper or copper peptide, is studied for skin repair, wound healing, collagen signaling, and inflammatory gene expression. Lab and skin-focused studies suggest GHK-Cu can affect genes tied to tissue remodeling and inflammation, but large human trials for arthritis, systemic inflammation, or autoimmune disease are not established 2, 3. Side effects can include skin irritation, rash, sensitivity, or allergy, especially with topical use.

Glutathione

Glutathione is an antioxidant tripeptide made from three amino acids: cysteine, glycine, and glutamate. It helps manage reactive oxygen species and supports antioxidant defense, which is relevant because oxidative stress and inflammation often amplify each other 4. Human research is mixed by condition, dose, route, and baseline health, so it should not be framed as a cure for chronic inflammation. Side effects can include nausea, cramping, headache, rash, or reactions to injectable products.

NAD+

NAD+, short for nicotinamide adenine dinucleotide, is a coenzyme involved in cellular metabolism, mitochondrial function, and aging biology. NAD+ pathways interact with inflammatory signaling and cellular stress responses in preclinical and translational research 5. Human data for NAD+ products and inflammation outcomes is still developing. Possible side effects vary by route and can include flushing, nausea, headache, dizziness, or injection-site reactions.

BPC-157

BPC-157, or body protection compound-157, is an experimental synthetic peptide widely promoted for gut, tendon, ligament, and joint recovery. Animal studies suggest effects on tissue repair and inflammatory injury models, but human evidence is limited, and it is not FDA-approved for inflammation, injury, arthritis, or chronic pain 6. Safety questions include product quality, immune reactions, unknown long-term risks, and lack of reliable human dosing data.

TB-500

TB-500 is commonly described online as a thymosin beta-4 fragment. Thymosin beta-4 has been studied in wound healing and tissue-repair biology, including effects on cell migration and repair signaling, but TB-500 products sold online are not the same as FDA-approved drugs for inflammation 7. Human safety data for gray-market TB-500 is limited. Risks include contamination, inaccurate strength, injection reactions, and unclear long-term effects.

GLP-1 and GIP/GLP-1 medicines

Wegovy and Ozempic contain semaglutide, a GLP-1 receptor agonist; semaglutide can also be prescribed as a compounded formulation through licensed 503A pharmacies when clinically appropriate. Zepbound and Mounjaro contain tirzepatide, a dual GIP/GLP-1 receptor agonist; tirzepatide can also be prescribed as a compounded formulation through licensed 503A pharmacies when clinically appropriate. These medicines are used for weight and metabolic care, not as direct inflammation treatments. In large trials of the active ingredients, weight and cardiometabolic changes were measured over 68 to 208 weeks, and individual results vary 8, 9, 10. Side effects can include nausea, vomiting, diarrhea, constipation, gallbladder problems, pancreatitis risk, and contraindications such as personal or family history of medullary thyroid carcinoma or MEN2 on certain FDA labels 10. Results are not established for compounded formulations.

Which peptide is best for inflammation?

There is no single best peptide for inflammation because inflammation is a process, not one diagnosis. The right conversation depends on whether the driver is injury, metabolic health, skin inflammation, autoimmune disease, infection, medication effects, or oxidative stress.

For skin-focused concerns, GHK-Cu may be a more relevant discussion. For oxidative stress biology, glutathione or NAD+ may come up. For weight-related metabolic inflammation, GLP-1 or GIP/GLP-1 medicines may be part of broader weight care, but they should not be presented as anti-inflammatory cures 8, 9.

How might peptides affect inflammation pathways?

Peptide mechanisms can sound simple online, but inflammation biology is complex. A compound may affect cytokines, oxidative stress, tissue repair, or metabolism in a lab model without improving pain, swelling, function, or disease activity in people.

• Immune signaling: some compounds are studied for effects on cytokines such as TNF-alpha, IL-6, and IL-1 beta, or the NF-kB pathway, which helps regulate inflammatory gene activity 1.
• Oxidative stress: glutathione and NAD+ pathways relate to reactive oxygen species and cellular stress responses, which can interact with chronic inflammation 4, 5.
• Tissue repair: GHK-Cu, BPC-157, and thymosin beta-4 research often focuses on collagen synthesis, angiogenesis, cell migration, or wound repair rather than proven chronic pain relief 2, 6, 7.
• Metabolic health: obesity and insulin resistance are linked with low-grade inflammation. Weight-loss medicines may improve metabolic risk factors, but they are not a stand-alone treatment for autoimmune disease, infection, or injury 8, 9.

Are BPC-157 and TB-500 anti-inflammatory?

BPC-157 and TB-500 are often described as anti-inflammatory or recovery peptides, but that language is stronger than the human evidence supports. They are better described as experimental peptides being studied for tissue-repair and inflammation-related biology.

BPC-157 has animal data in injury and inflammatory models, including gastrointestinal and musculoskeletal research, but it is not FDA-approved for inflammation, arthritis, joint pain, sports injury, or chronic pain 6. TB-500 is marketed as a thymosin beta-4 fragment, while published thymosin beta-4 research is not the same as proving that research-use TB-500 products are safe or effective for patients 7.

On July 23-24, 2026, the FDA Pharmacy Compounding Advisory Committee recommended BPC-157 and TB-500 for inclusion on the 503A Bulks List, while FDA staff had proposed against all seven peptides reviewed; six of seven were recommended, and Emideltide / DSIP was not recommended 11, 12.

Peptides for inflammation at Chia: what is available online?

At Chia, we offer clinician-reviewed access to select compounded peptide and longevity-related treatments, but we do not claim to treat, cure, or prevent inflammation, arthritis, autoimmune disease, injury, or chronic pain with peptides. Our role is to evaluate the full picture and prescribe only when clinically appropriate.

For skin-focused peptide care, Chia offers GHK-Cu Cream, currently from $159/mo. For oxidative-stress and longevity-focused conversations, Chia offers glutathione injection or nasal spray, with injection plans currently from $179/mo, and NAD+ injection or nasal spray, with nasal spray plans currently from $129/mo and injection plans currently from $179/mo.

Chia also offers the Foundation Longevity protocol, which includes Sermorelin Injection, NAD+ Injection, and Glutathione Injection from $399/mo, and the Glow protocol, which includes GHK-Cu Cream, Glutathione Injection, and NAD+ Injection from $349/mo. When weight and metabolic health are part of the conversation, our providers may also evaluate whether compounded semaglutide or tirzepatide fits the patient’s overall goals.

Treatment at Chia is 100% online. You complete a short health questionnaire, a licensed US provider reviews it, and medication is prescribed only when clinically appropriate. If prescribed, medications are compounded in the US by state-licensed 503A pharmacies and shipped to your door. Dosing, route, monitoring, and follow-up are provider-guided.

What are the possible side effects and safety concerns with peptides?

Peptide side effects depend on the compound, dose, route, and the person using it. The most common concerns include injection-site pain, redness, swelling, itching, rash, nausea, headache, flushing, dizziness, and allergic reactions.

Experimental peptides add another layer of risk. Research-use-only products may have inaccurate strength, contamination, unclear storage, or ingredients that are not listed on the label. FDA has warned that compounded drugs have not undergone FDA premarket review for safety, effectiveness, or quality 13.

A clinician should review pregnancy, breastfeeding, autoimmune disease, cancer history, kidney or liver disease, allergies, current medications, supplements, and recent procedures. This matters because inflammation symptoms can also come from infections, autoimmune flares, blood clots, fractures, or other problems that need standard medical care.

How should someone talk to a clinician about peptides for inflammation?

A good visit starts with the reason inflammation is suspected, not with a peptide name. Tell the clinician what hurts, what is swollen, how long it has been going on, and whether you have fever, weight change, fatigue, rashes, gut symptoms, or morning stiffness.

• Bring your diagnoses, including arthritis, autoimmune conditions, insulin resistance, obesity, skin conditions, or recent sports injury.
• List medications and supplements, including NSAIDs, steroids, biologics, DMARDs, blood thinners, hormones, GLP-1 medicines, antioxidants, and immune products.
• Ask what human evidence exists for the specific peptide, not just the mechanism.
• Ask which route is being considered, how monitoring works, and what side effects should prompt follow-up.
• Ask whether the medication comes from a state-licensed 503A compounding pharmacy and whether ongoing provider messaging is available.

Seek urgent care for chest pain, trouble breathing, one-sided leg swelling, high fever, severe abdominal pain, sudden weakness, rapidly spreading redness, or a hot swollen joint with fever. Peptides are not a substitute for emergency care or disease-specific treatment.

What else helps inflammation besides peptides?

Inflammation care often starts with diagnosis, sleep, movement, nutrition, stress, and standard treatment when needed. Peptides may be part of a broader clinician-guided plan for some people, but they should not replace proven care.

• Sleep: short or poor sleep can worsen pain sensitivity, appetite regulation, and immune balance.
• Exercise: regular aerobic and resistance training can support metabolic health and function, but acute injuries may need rest or physical therapy first.
• Nutrition: fiber-rich foods, protein adequacy, and lower alcohol intake can support cardiometabolic health.
• Weight management: for some people, obesity and insulin resistance contribute to chronic low-grade inflammation; GLP-1 or GIP/GLP-1 care may be discussed for weight management when appropriate 8, 9.
• Standard care: NSAIDs, steroids, DMARDs, antibiotics, physical therapy, or procedures may be appropriate depending on the diagnosis.

FAQ: peptides for inflammation

Keep reading

Peptides

Peptides Side Effects: What Patients Should Know Before Treatment

Peptides

Peptides Explained: What They Are, How They Work, and Which Ones Are FDA-Approved

Peptides

Wolverine Stack Peptides: What BPC-157 and TB-500 Are, and What the Evidence Says